
Search
Filter Results
Displaying 611–620 of 1063 results
-
Jul 22, 2020
Accepting grant applications for advancing retinal degeneration treatments toward human studies
-
Bronze Partner - Ora Clinical
-
Bronze Partner - MeiraGTx
-
Jul 17, 2020
A Phase 3 trial for the treatment is planned
-
Bronze Partner - Janssen Pharmaceutical Companies
Bronze Partner - Janssen Pharmaceutical Companies
-
Bronze Partner - AGTC
-
Gold Partner and Accessibility Underwriter - Spark Therapeutics
Gold Partner & Accessibility Underwriter Spark Therapeutics
-
Quarterly vision webinars providing key information impacting our community.
-
Jul 7, 2020
Biogen Entering into Licensing Agreement with Mass Eye and Ear to Develop PRPF31 Gene Therapy
The goal of the partnership is to advance a PRPF31 gene therapy into a clinical trial
-
Brint Family Translational Research Award
The Brint Family Translational Research Program awards will accelerate the movement of preclinical research toward an Investigational New Drug filing and into clinical trials to provide a robust and diverse pipeline of potential therapies to fight inherited retinal degenerations (IRD) and dry age-related macular degeneration.